Thinking of joining a study?

Register your interest

NCT06385275 | NOT YET RECRUITING | Osteo Arthritis Knee


The Role of Vitamin K on Knee Osteoarthritis Outcomes
Sponsor:

Boston University

Information provided by (Responsible Party):

Jean Liew

Brief Summary:

The appropriate form and dosing of vitamin K to benefit relevant outcomes in knee osteoarthritis (OA) are not known. In intervention studies for conditions other than knee OA (e.g., prevention of cardiovascular disease), the most commonly used forms and doses include phylloquinone (vitamin K1; 1000µg or 500µg daily) or menaquinone-7 (MK-7 or vitamin K2; 300µg daily). However, whether these doses are adequate to increase vitamin K to levels that ameliorate risk of adverse OA outcomes is not known. Furthermore, although some studies suggest enhanced bioavailability of MK-7 over vitamin K1, as well as extra-hepatic effects, whether this is relevant for an older population with knee OA is not known, The overall goal of this pilot randomized clinical trial (RCT) is to test different subtypes and doses of vitamin K supplementation in older adults with knee OA and to measure changes in relevant biochemical measures.

Condition or disease

Osteo Arthritis Knee

Intervention/treatment

Vitamin K1 500 µg

K1 1000 µg

Vitamin K2 (MK-7) 300 µg

Placebo

Phase

PHASE1

PHASE2

Study Type : INTERVENTIONAL
Estimated Enrollment : 55 participants
Masking : TRIPLE
Masking Description : Use of a placebo from Johnson Compounding Pharmacy (Waltham, MA) of similar appearance and taste to the vitamin K supplements will allow for masking of participants, the study PI, and other study team members to the treatment allocation.
Primary Purpose : TREATMENT
Official Title : The Role of Vitamin K on Knee Osteoarthritis Outcomes
Actual Study Start Date : 2024-09
Estimated Primary Completion Date : 2026-12
Estimated Study Completion Date : 2026-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 60 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * ≥60 years old
  • * Clinical diagnosis of knee OA by the treating rheumatologist
  • * English fluency
Exclusion Criteria
  • * Anticoagulation use (including warfarin, dabigatran, rivaroxaban, apixaban)

The Role of Vitamin K on Knee Osteoarthritis Outcomes

Location Details

NCT06385275


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Massachusetts

Boston Medical Center, Rheumatology Clinic

Boston, Massachusetts, United States, 02118

Loading...